Couldn't agree more on the questions. The next Q&A
Post# of 148242
That's what is ultimately killing the stock price... the speed of enrollment. It's the reason we're in a constant state of waiting, waiting, waiting bc it's damn hard to recruit patients when the FDA is touting an inferior drug as the standard of care. Patients hear that phrase and assume it's the best possible treatment they can get, so why opt for an experimental shot?